Point72 Asset Management L.P. Takes Position in Trupanion, Inc. (NASDAQ:TRUP)

Point72 Asset Management L.P. acquired a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 30,775 shares of the financial services provider's stock, valued at approximately $1,483,000. Point72 Asset Management L.P. owned 0.07% of Trupanion at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Amundi grew its stake in Trupanion by 193.2% during the fourth quarter. Amundi now owns 16,828 shares of the financial services provider's stock valued at $784,000 after acquiring an additional 11,088 shares in the last quarter. Barclays PLC grew its stake in Trupanion by 259.2% during the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock valued at $2,750,000 after acquiring an additional 47,262 shares in the last quarter. Vanguard Group Inc. grew its stake in Trupanion by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock valued at $173,362,000 after acquiring an additional 45,653 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Trupanion by 112.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock valued at $13,204,000 after acquiring an additional 144,828 shares in the last quarter. Finally, Wealthfront Advisers LLC purchased a new position in Trupanion during the fourth quarter valued at $845,000.

Insider Transactions at Trupanion

In other news, insider Brenna Mcgibney sold 5,000 shares of Trupanion stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $32.99, for a total transaction of $164,950.00. Following the completion of the sale, the insider now owns 3,738 shares of the company's stock, valued at approximately $123,316.62. The trade was a 57.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $45.86, for a total transaction of $183,440.00. Following the sale, the chief executive officer now directly owns 118,784 shares of the company's stock, valued at $5,447,434.24. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 37,792 shares of company stock worth $1,306,242. 5.42% of the stock is currently owned by insiders.

Trupanion Price Performance

Shares of NASDAQ:TRUP traded up $2.61 on Tuesday, reaching $47.15. The company's stock had a trading volume of 113,542 shares, compared to its average volume of 605,560. Trupanion, Inc. has a 52-week low of $25.90 and a 52-week high of $57.90. The company has a market cap of $2.02 billion, a P/E ratio of -204.76, a PEG ratio of 6.02 and a beta of 1.72. The company has a 50-day simple moving average of $39.09 and a 200 day simple moving average of $43.94. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02. The business had revenue of $341.98 million during the quarter, compared to analysts' expectations of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business's revenue was up 11.7% on a year-over-year basis. During the same period last year, the company posted ($0.16) EPS. As a group, equities research analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on TRUP. Piper Sandler cut their target price on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research note on Thursday, February 20th. Lake Street Capital cut their target price on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Finally, Stifel Nicolaus dropped their price objective on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research note on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Trupanion presently has an average rating of "Moderate Buy" and an average target price of $51.80.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.